Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/6QC stock hub

FRA/6QC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/6QCis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1B
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/6QCFRA/6QC
Loading chart…
In the news

Latest news · FRA/6QC

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E9
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC6.4
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/6QC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
194
Groups with data
11
Currency
JPY
Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Japan
Country code
DE
Employees
4,788
Employees Change
200%
Employees Change Percent
4.36
Enterprise value
EUR 2.1B
Exchange
Frankfurt Stock Exchange
Financial currency
JPY
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
EUR 1B
Price
EUR 20.8
Price currency
EUR
Rev Per Employee
306,237.22x
Sic
2834
Symbol
fra/6QC
Website
https://www.towayakuhin.co.jp

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
11.16%
EV Earnings
17.99x
EV/EBIT
16.01x
EV/EBITDA
8.35x
EV/FCF
60.87x
EV/Sales
1.43x
FCF yield
3.3%
P/B ratio
1.01x
P/E ratio
8.96x
P/S ratio
0.71x
PE Ratio10 Y
12.28x
PE Ratio3 Y
13.04x
PE Ratio5 Y
12.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
FCF margin
2.35%
Gross Profit
EUR 538.4M
Gross Profit Growth
8.06%
Gross Profit Growth Q
8.07%
Gross Profit Growth3 Y
13.67%
Gross Profit Growth5 Y
10.7%
Net Income
EUR 116.5M
Net Income Growth
11.23%
Net Income Growth Q
9.9%
Net Income Growth3 Y
94.87%
Net Income Growth5 Y
10.56%
Pretax Margin
10.54%
Profit Per Employee
EUR 24,329
Roa5y
3.25
ROCE
6.1
Roe5y
9.94
ROIC
6.43
Roic5y
4.89

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

13
MetricValue
Cagr1y
35.67%
Cagr3y
20.28%
Div CAGR3
1.66%
Div CAGR5
-60.09%
EPS Growth
11.22
EPS Growth Q
9.9
EPS Growth3 Y
95.25
EPS Growth5 Y
11.39
OCF Growth
98.51%
Revenue Growth
6.54x
Revenue Growth Q
4.63x
Revenue Growth3 Y
14.37x
Revenue Growth5 Y
13.83x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Assets
EUR 2.7B
Cash
EUR 216.3M
Current Assets
EUR 1.4B
Current Liabilities
EUR 505.1M
Debt
EUR 1.3B
Debt Equity
EUR 1.23
Debt FCF
EUR 36.87
Equity
EUR 1B
Interest Coverage
11.24
Liabilities
EUR 1.6B
Long Term Assets
EUR 1.2B
Long Term Liabilities
EUR 1.1B
Net Cash
EUR -1.1B
Net Cash By Market Cap
EUR -101
Net Debt EBITDA
EUR 4.19
Net Debt Equity
EUR 1.02
Net Debt FCF
EUR 30.58
Tangible Book Value
EUR 798.2M
Tangible Book Value Per Share
EUR 16.21

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
2.83
Net Working Capital
EUR 888.8M
Quick ratio
1.3
Working Capital
EUR 930.3M
Working Capital Turnover
EUR 0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
-0.01%
Dividend Growth
3.46%
Dividend Growth Years
1%
Dividend per share
EUR 0.45
Dividend Years
7
Dividend Yield
2.14%
Ex Div Date
2026-03-30
Last Dividend
EUR 0.22
Payout Frequency
Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

33
MetricValue
1Y total return
35.64%
200-day SMA
18.87
3Y total return
74.03%
50-day SMA
22.08
50-day SMA vs 200-day SMA
50over200
All Time High
26.53
All Time High Change
-21.58%
All Time High Date
2021-10-22
All Time Low
10.9
All Time Low Change
90.83%
All Time Low Date
2023-07-11
ATR
0.51
Ch YTD
7.22
High
20.8
High52
23.6
High52 Date
2026-02-27
High52ch
-11.86%
Low
20.8
Low52
14.6
Low52 Date
2025-05-15
Low52ch
42.47%
Ma50ch
-5.81%
Price vs 200-day SMA
10.26%
RSI
42.81
RSI Monthly
56.93
RSI Weekly
53.03
Sharpe ratio
0.86x
Sortino ratio
1.56
Total Return
2.13%
Tr YTD
8.27
Tr1m
-7.96%
Tr1w
-6.31%
Tr3m
9.97%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 131M
Operating Income Growth
9.38
Operating Income Growth Q
27.47
Operating Income Growth3 Y
51.79
Operating Income Growth5 Y
7.49
Operating margin
8.94

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
23,011,267%
Net Borrowing
4,779,307.8
Shares Insiders
3%
Shares Institutions
23.02%
Shares Qo Q
0%
Shares Yo Y
0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

54
MetricValue
Adjusted FCF
EUR 34.4M
Average Volume
12x
Bv Per Share
20.93
CAPEX
EUR -133M
Ch1m
-7.96
Ch1w
-6.31
Ch1y
32.48
Ch3m
8.9
Ch3y
62.5
Ch6m
35.95
Change
-2.8%
Change From Open
0
Close
21.4
Days Gap
-2.8
Depreciation Amortization
119,742,498.5
Earnings Date
2026-05-14
EBIT
EUR 131M
EBITDA
EUR 251.2M
EPS
EUR 2.37
F Score
5
FCF
EUR 34.4M
FCF EV Yield
1.64x
Financing CF
33,071,087
Fiscal Year End
March
Founded
1,951
Goodwill
137,241,368.3
Graham Number
32.73713
Graham Upside
57.39
Income Tax
EUR 38M
Investing CF
-150,715,723
Is Primary Listing
0
Last Earnings Date
2026-02-13
Last Report Date
2025-12-31
Lynch Fair Value
EUR 24.51
Lynch Upside
17.81
Ma150
19.4
Ma150ch
7.24%
Ma20
21.88
Ma20ch
-4.94%
Net CF
56,060,056
Next Earnings Date
2026-05-14
Open
20.8
P FCF Ratio
30.33
P OCF Ratio
6.23
Payment Date
2026-06-26
Ppne
927,028,745.6
Price Date
2026-05-08
Price EBITDA
EUR 4.16
Ptbv Ratio
1.31
Relative Volume
18.58x
Revenue
1,466,263,810x
Tax By Revenue
2.59x
Tr6m
37.28%
Volume
0
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

FRA/6QC dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+2.1%
$0.45 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
-60.1%
1 consecutive years of growth
Total shareholder yield
+2.1%
Next ex-dividend date: 2026-03-30
Performance

FRA/6QC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+35.6%
S&P 500 1Y: n/a
3Y total return
+74.0%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns FRA/6QC?

Insider, institutional, and short-interest positioning.

Institutional ownership
+23.0%
Share of float held by funds and institutions
Insider ownership
+3.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.0%
Negative means the company is buying back shares.
Technical

FRA/6QC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
42.8
Neutral momentum band
Price vs 200-day MA
+10.3%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.86
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/6QC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/6QC stock rating?

fra/6QC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/6QC analysis?

The full report lives at /stocks/fra/6QC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/6QC?

The latest report frames fra/6QC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/6QC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.